Related references
Note: Only part of the references are listed.Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations
Chishala Chabala et al.
CLINICAL INFECTIOUS DISEASES (2022)
Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children
Kendra K. Radtke et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children
Erika Wallender et al.
NATURE COMMUNICATIONS (2021)
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial
Anthony J. Garcia-Prats et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Population Pharmacokinetic Properties of Antituberculosis Drugs in Vietnamese Children with Tuberculous Meningitis
Navarat Panjasawatwong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania
Museveni Justine et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection
Jennifer E. Hibma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis
Boi-Lam Hong et al.
CLINICAL THERAPEUTICS (2020)
Pharmacokinetics of isoniazid in Indian children with tuberculosis on daily treatment
I. Shah et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2019)
Current research toward optimizing dosing of first-line antituberculosis treatment
Helen McIlleron et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)
Alternative dosing guidelines to improve outcomes in childhood tuberculosis: a mathematical modelling study
Kendra K. Radtke et al.
LANCET CHILD & ADOLESCENT HEALTH (2019)
Prevalence and Socio-economic Impacts of Malnutrition Among Children in Uganda
Yusuff Adebayo Adebisi et al.
NUTRITION AND METABOLIC INSIGHTS (2019)
The burden of child and maternal malnutrition and trends in its indicators in the states of India: the Global Burden of Disease Study 1990-2017
Soumya Swaminathan et al.
LANCET CHILD & ADOLESCENT HEALTH (2019)
Evaluation of the Adequacy of WHO Revised Dosages of the First-Line Antituberculosis Drugs in Children with Tuberculosis Using Population Pharmacokinetic Modeling and Simulations
Yasuhiro Horita et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pharmacokinetic study of isoniazid and pyrazinamide in children: impact of age and nutritional status
Rajeshwar Dayal et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2018)
Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV-Coinfected Children in India: Recommendations for Dose Modifications
Benjamin Guiastrennec et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Isoniazid and rifampicin concentrations in children with tuberculosis with either a daily or intermittent regimen: implications for the revised RNTCP 2012 doses in India
Jaya Ranjalkar et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children
M. Nansumba et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis
K. E. Stott et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations
Robin J. Svensson et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Marjorie Z. Imperial et al.
NATURE MEDICINE (2018)
Evidence-Based Design of Fixed-Dose Combinations: Principles and Application to Pediatric Anti-Tuberculosis Therapy
Elin M. Svensson et al.
CLINICAL PHARMACOKINETICS (2018)
Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV Coinfection
Sampson Antwi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis
R. E. Aarnoutse et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines
A. Bekker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests
Soumya Swaminathan et al.
CLINICAL INFECTIOUS DISEASES (2016)
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children
A. Mukherjee et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
Martin J. Boeree et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
Aparna Mukherjee et al.
BMC INFECTIOUS DISEASES (2015)
Rifampicin pharmacokinetics in children under the Revised National Tuberculosis Control Programme, India, 2009
A. Arya et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol
R. Mlotha et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
The Effect of Malnutrition on the Pharmacokinetics and Virologic Outcomes of Lopinavir, Efavirenz and Nevirapine in Food Insecure HIV-infected Children in Tororo, Uganda
Imke H. Bartelink et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Pharmacokinetics of First-Line Antituberculosis Drugs in HIV-Infected Children with Tuberculosis Treated with Intermittent Regimens in India
Geetha Ramachandran et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Subtherapeutic concentrations of first-line anti-TB drugs in South African children treated according to current guidelines: the PHATISA study
Hiwot Hiruy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Practical Considerations for Dose Selection in Pediatric Patients to Ensure Target Exposure Requirements
April M. Barbour et al.
AAPS JOURNAL (2014)
Correction: The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data
PLOS MEDICINE (2014)
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy
Junichi Azuma et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children
G. Ramachandran et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
Jotam G. Pasipanodya et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Blood levels of pyrazinamide in children at doses administered under the revised national tuberculosis control program
V. Roy et al.
INDIAN PEDIATRICS (2012)
Risk Factors for In-Hospital Mortality Among Children With Tuberculosis: The 25-Year Experience in Peru
Peter C. Drobac et al.
PEDIATRICS (2012)
Pharmacokinetics of Isoniazid, Rifampin, and Pyrazinamide in Children Younger than Two Years of Age with Tuberculosis: Evidence for Implementation of Revised World Health Organization Recommendations
S. Thee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Share Paper
